; (II) any corrective actions that may be taken; and (III) any other actions that may be taken to promote the use of private capital and to increase the amount of Federal funds made available to carry out basic and translational biomedical research; and (ii) make publicly available the report described in clause (i). (3) Effect on eye bonds issued and Federal guarantees The termination of the Program shall not affect the validity of— (A) any eye bond issued before the date on which the Program is terminated; or (B) any Federal guarantee under this Act for an eye bond described in subparagraph (A). (g) Program funding (1) Administrative expenses paid from bond sales Except as provided under paragraph (2), the cost of carrying out this Act, including the cost to the Secretary in administering the Program, shall be recovered from the proceeds from the sale of eye bonds pursuant to the Program or from fees as set forth in paragraph (3). (2) Specific appropriation or contribution No guarantee shall be made under this section unless— (A) an appropriation for the full cost of the guarantee has been made; (B) the Secretary has received from the eye bond issuer a payment in full for the cost of the guarantee; or (C) a combination of an appropriation and the deposit of a payment from the bond issuer into the Treasury has been made in a sufficient amount to cover the full cost of the guarantee. (3) Cost of Guarantees (A) In general The Secretary shall charge and collect fees for guarantees under this section in amounts the Secretary determines are sufficient to recover applicable administrative expenses. (B) Availability Fees collected under this subsection— (i) shall be deposited by the Secretary into the Treasury